Celanese Corporation Cash Flow Conversion Efficiency
Celanese Corporation cash flow conversion efficiency. Based on the latest financial reports, Celanese Corporation (CE) has a cash flow conversion efficiency ratio of 0.062x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($285.00 Million) by net assets ($4.59 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Celanese Corporation (2001–2025)
Cash flow conversion efficiency of Celanese Corporation from 2001 to 2025. This chart illustrates how Celanese Corporation's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Celanese Corporation (CE) share price today for real-time trading data and today's change.
Celanese Corporation Cash Flow Conversion Ratio Explained
Celanese Corporation cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Celanese Corporation Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Celanese Corporation ranked by their cash flow conversion efficiency. Also see Celanese Corporation (CE) total market value for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Charoen Pokphand Foods Public Company Limited
BK:CPF
|
0.051x |
|
E-L Financial Corp Ltd
TO:ELF
|
0.019x |
|
Eastern Bankshares Inc
NASDAQ:EBC
|
0.036x |
|
Bumrungrad Hospital PCL
BK:BH
|
0.050x |
|
Crocs Inc
NASDAQ:CROX
|
-0.037x |
|
Montage Gold Corp.
TO:MAU
|
-0.017x |
|
Lifan Industry Group Co Ltd
SHG:601777
|
0.105x |
|
SIG Combibloc Group AG
SW:SIGN
|
0.185x |
Annual Cash Flow Conversion Efficiency for Celanese Corporation (2001–2025)
The table below shows the annual cash flow conversion efficiency of Celanese Corporation from 2001 to 2025. Review Celanese Corporation free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $4.47 Billion | $1.15 Billion | 0.256x | +48.80% |
| 2024-12-31 | $5.61 Billion | $966.00 Million | 0.172x | -31.51% |
| 2023-12-31 | $7.55 Billion | $1.90 Billion | 0.251x | -15.61% |
| 2022-12-31 | $6.11 Billion | $1.82 Billion | 0.298x | -23.06% |
| 2021-12-31 | $4.54 Billion | $1.76 Billion | 0.387x | +77.46% |
| 2020-12-31 | $3.90 Billion | $850.00 Million | 0.218x | -56.50% |
| 2019-12-31 | $2.90 Billion | $1.45 Billion | 0.502x | +8.81% |
| 2018-12-31 | $3.38 Billion | $1.56 Billion | 0.461x | +89.43% |
| 2017-12-31 | $3.30 Billion | $803.00 Million | 0.243x | -17.66% |
| 2016-12-31 | $3.02 Billion | $893.00 Million | 0.296x | -2.99% |
| 2015-12-31 | $2.83 Billion | $862.00 Million | 0.305x | -2.51% |
| 2014-12-31 | $3.08 Billion | $962.00 Million | 0.313x | +10.70% |
| 2013-12-31 | $2.70 Billion | $762.00 Million | 0.282x | -32.35% |
| 2012-12-31 | $1.73 Billion | $722.00 Million | 0.417x | -12.28% |
| 2011-12-31 | $1.34 Billion | $638.00 Million | 0.476x | -2.74% |
| 2010-12-31 | $924.00 Million | $452.00 Million | 0.489x | -52.07% |
| 2009-12-31 | $584.00 Million | $596.00 Million | 1.021x | -67.96% |
| 2008-12-31 | $184.00 Million | $586.00 Million | 3.185x | +500.38% |
| 2007-12-31 | $1.07 Billion | $566.00 Million | 0.530x | -39.18% |
| 2006-12-31 | $861.00 Million | $751.00 Million | 0.872x | -63.47% |
| 2005-12-31 | $299.00 Million | $714.00 Million | 2.388x | +1638.91% |
| 2004-12-31 | $406.00 Million | $-63.00 Million | -0.155x | -200.61% |
| 2003-12-31 | $2.60 Billion | $401.00 Million | 0.154x | -10.95% |
| 2002-12-31 | $2.10 Billion | $363.00 Million | 0.173x | -26.75% |
| 2001-12-31 | $1.95 Billion | $462.00 Million | 0.236x | -- |
About Celanese Corporation
Celanese Corporation produces and sells engineered polymers worldwide. It operates through Engineered Materials and Acetyl Chain segments. The company offers ethylene acrylic elastomers, ethylene vinyl acetate pharmaceutical grade copolymers, liquid crystal polymers, long-fiber reinforced thermoplastics, nylon and polypropylene compounds and formulations, polyoxymethylene, ultra-high molecular we… Read more